首頁
老師簡介
C.V.
研究領域
聯絡資訊
實驗設備
實驗室人員
教學資源
我們的照片

Curriculum Vitae　 　　Publications　　　Conference

Research

Conference

  1. Lin, J. K., Hour, T. C., Lee, C. C. and Lin-Shiau, S. Y. (1997) New salmonella tester strains for detecting point and frameshift mutagens. Proceedings of the 1st International Conference of Asian Society of Toxicology, p131.

  2. Hour, T. C., Guan, J. Y., Lu S. H., Huang, C. Y., Yang, C. H. and Pu, Y. S. (2000) Buthionine sulfoximide may sensitize cells to arsenic trioxide: a novel therapeutic strategy for transitional carcinomas. Proceedings of the 91th American Association for Cancer Research, Vol. 41, p178 (#1138).

  3. Hour, T. C., Huang, C. Y., Guan, J. Y., Lu S. H., Cheng J and Pu, Y. S. (2000) Curcumin enhances doxorubicin cytotoxicity in prostate cancer cells by suppression of NF-kB activation and induction of p21WAF1/CIP1 and C/EBPb expressions. Proceedings of the 5th annual conference of Taiwan Cancer Association.

  4. Hour, T. C., Guan, J. Y., Lu, S. H., Huang, C. Y., Yang, C. H. and Pu, Y. S. (2000) Arsenic cytotoxicity to transitional carcinomas cells is through reactive oxygen species-related apoptotic pathways. Proceedings of the 12th annual conference of the Urological Association of Taiwan, p24.

  5. Hour, T, C., Huang, C. Y., Guan, J. Y., Lu, S. H., Cheng, J. and Pu, Y. S. (2000) Schedule-dependence of combined treatment of BSO and arsenic-optimizing cytotoxic effect to transitional carcinoma cells. Proceedings of the 12th annual conference of the Urological Association of Taiwan, p28.

  6. Hour, T. C. Chen, J., Huang, C. Y., Guan, J. Y., Lu, S. H. and Pu, Y. S. (2001) Characterization of the molecular events in a series of bladder carcinoma cells with progressive arsenic trioxide resistance. Proceedings of the 92th American Association for Cancer Research, Vol. 42, p645 (#3470).

  7. Hour, T. C., Pu, Y. S., Chen, J., Huang, C. Y., Guan, J. Y., and Lu, S. H. (2001) Characterization of arsenic cytotoxicity to transitional carcinoma cells: emphases on cross-resistance to cisplatin and exploration of apoptotic pathway. Proceedings of the 5th International Conference of the Asian Clinical Oncology Society and the 6th Taiwan Joint Cancer Conference, p73 (A-20).

  8. Pu, Y. S., Hour, T. C., Huang, C. Y., Guan, J. Y., and Lu, S. H., and Chen, J. (2001) Differential expressions of molecular markers in androgen-dependent and independent prostate cancer cells, Proceedings of the 13th annual conference of the Urological Association of Taiwan, p229 (C23).

  9. Hour, T. C., Pu, Y. S., Huang, C. Y., Guan, J. Y., and Lu, S. H., and Chen, J. (2001) Molecular Events in a Series of Bladder Carcinoma Cells with Progressive Resistance to Arsenic Trioxide, Proceedings of the 13th annual conference of the Urological Association of Taiwan, p124 (A28).

  10. Hour, T. C. Huang, C. Y., Guan, J. Y., Lu, S. H. Chen, J. and Pu, Y. S. (2002) Differential expressions of molecular markers in androgen-dependent and independent prostate cancer cells, Proceedings of the 93th American Association for Cancer Research, Vol. 43, p382 (#1901).

  11. Yang, S. H., Chien, C. M., Tsai, C. H., Lu, Y. J., Horng, C. J., Hour, T. C. and Lin, S. R. (2003) In vitro antitumor activity of cardiotoxins. The Annual Meeting of Chinese Chemistry Society. OR-19.

  12. Hour, T. C., Huang, S. W., Lin, C. C., Huang, C. Y., Chen, J., Chiu, A. W., Chen, C. J., Pu, Y. S. (2004) Expression of molecular markers in arsenic-related bladder urothelial carcinoma ---distinction from non-arsenic related BUC in Taiwan. Proceedings of the 95th American Association for Cancer Research, Vol. 45, p266 (#1164).

  13. Hour, T. C., Wang, C. W., Hsieh, M. W., Chin, H. C., Kuo, Y. Z., Huang C. Y., Guan, J. Y. and Pu, Y. S. (2005) Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells. Proceedings of the International Chemical Congress of Pacific Basin Societies, p231.

  14. Huang, A. M., Guan, J. Y., Pu, Y. S. and Hour, T. C. (2007) The molecular roles of transcription factor C/EBPdelta in cisplatin-resistant urothelial carcinoma cells. 第15屆細胞及分子生物新知研討會, p266.

  15. Hour, T. C., Kuo, Y. Z., Kang, W. Y., Yu, H. J., Huang, S. P., Wu, W. J., Huang, C. H., Chai, C. Y., Pu, Y. S. (2007) Down-regulation of ABCD1 may be involved in tumorigenesis of human renal cell carcinoma. The 12th Taiwan Joint Cancer Conference and 6th Cross-Strait Academic Conference on Oncology, p112 (A-I-08).

  16. Kuo, Y. Z., Hour, T. C., Kang, W. Y., Liu, G. Y., Huang, A. M., Chen, C. J., Shiu , Y. S., Kuan, C. I., Wu, J. E., Pu, Y. S. (2007) Membranous or cytoplasmic localization of EGFR may be associated with human renal tumorigenesis. The 12th Taiwan Joint Cancer Conference and 6th Cross-Strait Academic Conference on Oncology, p113 (A-I-09).

  17. Chen, C. J.,  Hour, T. C., Kuo, Y. Z., Kang, W. Y., Huang, S. P., Wu, W. J., Huang, C. Y., Yu, H. J., Pu, Y. S. (2007) Down-regulation of PKCζ in human renal cell carcinoma.  The 12th Taiwan Joint Cancer Conference and 6th Cross-Strait Academic Conference on Oncology, p114 (A-I-10).

  18. Kuan, C. I., Huang, A. M., Hour, T. C., Liu, G. Y., Wu, J. E., Kuo, Y. Z., Chen, C. J., Shiu , Y. S., Huang, K. H., Pu, Y. S. (2007)  Mechanism of cisplatin-resistance in overexpression of C/EBP δ urothelial Carcinoma cells was through inhibition of P53 phosphorylation, Bcl-2 down-regulation and ERK inactivation. The 12th Taiwan Joint Cancer Conference and 6th Cross-Strait Academic Conference on Oncology, p118 (A-I-15).

  19. Hour, T. C., Kuo, Y. Z., Kang, W. Y., Yu, H. J., Huang, S. P., Wu, W. J., Pu, Y. S. (2007) Down-regulation of ABCD1 may be involved in tumorigenesis of human renal cell carcinoma. The 32nd FEBS Congress, FEBS Journal, vol 274, suppl 1, p177 (C2-112).

  20. Huang, S. P., Liu, C. C., Kang, W. Y., Hour, T. C., Lin, H. C., Wu, W. J., Huang, C. H., Wang, J. S., Yu, C. C., Wu, T. T., Ming-Tsang Wu, M. T., Chang. C. P. (2007) E-cadherin -160 C/A Polymorphism and Prostate Cancer Risk in Taiwan. Proceedings of the 29th annual conference of the Urological Association of Taiwan

  21. Huang, S. P., Yu, C. C., Liu, C. C., Huang, C. Y., Wang, J. S. Pu, Y. S., Yu, H. J., Wu, T. T., Huang, C. H., Wu, W. J., Kang, W. Y., Hour, T. C., Ming-Tsang Wu. (2008) Prognostic significance of cyclin D1 A870G polymorphisms on prostate specific antigen recurrence in prostate cancer post-radical prostatetomy. The 6th Taiwan Surgical Association Conference.

  22. Lai, Y. L., Kuan, C. I., Hour, T. C., Pu, Y. S., Huang, A. M. (2008) The molecular roles of transcription factor CEBPD-mediated cisplatin response in urothelial carcinoma cells. The 23rd Joint Annual Conference of Biomedical Sciences.

  23. Lai, Y. L., Kuan, C. I., Hour, T. C., Pu, Y. S. and Huang, A. M. (2009) Characterization of CEBPD-mediated cisplatin response and resistance in urothelial carcinoma cells. The 17th symposium on recent advances in cellular and molecular biology.

  24. Kao, Y. T., Toh S., Lin P. Y., Hour, T. C., Pu, Y. S. and Huang, A. M. (2009) Proteomic approaches on CEBPD-mediated gemcitabine response in human urothelial carcinoma cells. The 17th symposium on recent advances in cellular and molecular biology.

  25. Huang, A. M., Lai, Y. L., Kuan C. I., Pu, Y.S., and Hour, T. C. (2009) The molecular mechanism of CEBPD-mediated cisplatin response in urothelial carcinoma cells. Genome Instability and DNA Repair (Keystone conference).

  26. Chung, S. J., Hour, T. C., Huang, A. M., Liu, G. Y., Huang, S. P., Whang, S. T. and Pu, Y. S. (2009) Molecular characterization of human docetaxel-resistant prostate cancer cells. The 14th Taiwan Joint Cancer Conference.

  27. Liu, F. T., Hour, T. C., Kang, W. Y., Yu, H. J., Huang, C. Y., Pan, B. W., Wu, W. J., Huang, C. H. and Pu, Y. S. (2009) Chemokine CXCL14 (BRAK) expression and potential role in human renal cell carcinoma. The 14th Taiwan Joint Cancer Conference.

  28. Huang, A. M., Lai,Y. L., Kuan, C. K., Sterneck, E., Wu, W. J., Pu, Y. S. and Hour, T. C. (2010) CEBPD induces SOD1 and cisplatin resistance in urothelial carcinoma. Proceedings of the 101th American Association for Cancer Research, p1613.